SIAH1 reportedly behaves as a tumour suppressor during tumourigenesis by binding to numerous proteins, such as NcoR, TRAF, β-catenin, c-Myb, APC, and Kid, and thereby triggers their ubiquitylation and degradation via the ubiquitin–proteasome pathway [9–12]. Here, SIAH1 is linked to neoplasm.